Photobiomodulation

Slowing down the ageing process
Photobiomodulation allows to treat the initial aging signs through the application of the infrared laser which serves to stimulate the activity of free radicals and oxygen present in the cells, reducing the process of aging and apoptosis (cell death).
In the initial phases, by biomodulating the ROS (Reactive Oxygen Species) activity on mitochondrial cytochromes at low energy, a reduction in apoptosis leads to an increase in:
  • fibroblast proliferation - type I collagen for increasing TIMs inhibiting metalloproteases;
  • hyaluronic acid synthesis;
  • endothelial cells.
The ROSs (Reactive Oxygen Species H²O²-²O²) react very quickly in a few milliseconds:
  • at low doses they oxidise aged molecules and bacteria,
  • at high doses they are toxic (apoptosis) for living cells (photodynamic therapy)

Therapy Photobiostimulation

  • info_outline Read More

    The Eufoton® instruments indicated for this type of treatment are:
    •    LASEmaR® 500 combined with Lightscan™ - a fractional selective photothermolysis scanner, removes pigmentations and microectasias with significant improvements in the epidermal tissue.
    •    LASEmaR® 800 allows both procedures: photobiomodulation and skin remodelling with skin regeneration in the different stages of photochrome ageing.
    •    LASEmaR® 1500 combined with Lightscan™ fractional technology is particularly indicated for deep wrinkles, scars, pigmented and senile lesions, acne scars, firming, shrinking of pores.
     

Find your laser

Are you interested in a laser or in an accessory?

commentAsk for consulationcomment
REQUEST FOR CONSULTATION

Do you need help? Fill in the form and we will help you solve it.

!

!

Disclosures
Some of the information contained in this website are exclusively directed to healthcare professionals, in compliance with art. 21 of the Decree n. 46 of February 24th, 1997 and subsequent modifications and integrations, and the Guidelines of the Italian Ministry of Health of March 28th, 2013. The possibility to continue browsing and access to the content relating to products, technical descriptions and commercial offers is subject to the statement made by the user, under his own responsibility, to be a healthcare professional. The simple visitors will be redirected to institutional page of Eufoton.
Cookie Policy

This website uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Find out more by clicking here. ABILITA or DISABILITA.

By pressing Continue I declare under my own responsibility to be a healthcare provider and continuing to browse I declare to accept the cookie information.

I am a health worker
Continue arrow_forward
I am a visitor
Home arrow_forward